12-123781140-T-C
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1
The NM_001372106.1(DNAH10):āc.682T>Cā(p.Ser228Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.631 in 1,613,600 control chromosomes in the GnomAD database, including 325,110 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_001372106.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAH10 | NM_001372106.1 | c.682T>C | p.Ser228Pro | missense_variant | 6/79 | ENST00000673944.1 | NP_001359035.1 | |
LOC105370044 | XR_945481.4 | n.495+7353A>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAH10 | ENST00000673944.1 | c.682T>C | p.Ser228Pro | missense_variant | 6/79 | NM_001372106.1 | ENSP00000501095 | P1 |
Frequencies
GnomAD3 genomes AF: 0.634 AC: 96171AN: 151764Hom.: 30940 Cov.: 30
GnomAD3 exomes AF: 0.667 AC: 167460AN: 251206Hom.: 56911 AF XY: 0.666 AC XY: 90484AN XY: 135810
GnomAD4 exome AF: 0.631 AC: 922399AN: 1461720Hom.: 294136 Cov.: 62 AF XY: 0.633 AC XY: 460440AN XY: 727162
GnomAD4 genome AF: 0.634 AC: 96251AN: 151880Hom.: 30974 Cov.: 30 AF XY: 0.640 AC XY: 47528AN XY: 74222
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 19, 2019 | This variant is associated with the following publications: (PMID: 30389748, 31178129) - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at